BID | 114.60 | ASK | 115.10 | ||
Open | 118.69 | Previous Close | 119.30 | ||
Pre-Market | - | After-Market | 114.60 | ||
- - | -0.39 -0.34% |
Target Price | 136.25 | Analyst Rating | Moderate Buy 1.92 | |
Potential % | 18.49 | Finscreener Ranking | ★★ 47.44 | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ★★ 48.12 | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | ★★★★+ 63.60 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | ★★ 40.88 | |
Market Cap | 35.12B | Earnings Rating | Neutral | |
Price Range Ratio 52W % | 71.01 | Earnings Date | 16th Feb 2021 |
Today's Price Range 113.34118.83 | 52W Range 61.13136.98 | 5 Year PE Ratio Range 9.1042.40 |
Summary:
Neutral
Technical Indicators: | Neutral |
Moving Averages: | Sell |
Performance | |||
---|---|---|---|
1 Week | -5.80% | ||
1 Month | -6.65% | ||
3 Months | -0.14% | ||
6 Months | 18.96% | ||
1 Year | 36.37% | ||
3 Years | 70.23% | ||
5 Years | 192.30% | ||
10 Years | 256.29% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 14.11 | |||
ROE last 12 Months | 16.03 | |||
ROA (5Y Avg) | 6.93 | |||
ROA last 12 Months | 8.07 | |||
ROC (5Y Avg) | 10.27 | |||
ROC last 12 Months | 10.83 | |||
Return on invested Capital Q | 4.19 | |||
Return on invested Capital Y | 10.82 | |||
Assets Turnover | 0.60 | |||
Receivables Turnover | 5.50 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
47.00 | ||||
7.76 | ||||
6.87 | ||||
31.20 | ||||
43.00 | ||||
3.92 | ||||
93.43 | ||||
15.73 | ||||
38.45B | ||||
Forward PE | 28.19 | |||
PEG | 5.22 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.40 | ||||
2.10 | ||||
0.31 | ||||
0.52 | ||||
13.10 | ||||
Leverage Ratio | 2.00 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
53.40 | ||||
16.70 | ||||
22.60 | ||||
16.70 | ||||
14.50 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
5.53B | ||||
18.11 | ||||
4.71 | ||||
6.04 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.62 | ||||
0.78 | ||||
8.99 | ||||
11.37 | ||||
Payout ratio | 31.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q01 2021 | 0.89 | 1.06 | 19.10 |
Q04 2020 | 0.91 | 0.98 | 7.69 |
Q03 2020 | 0.66 | 0.78 | 18.18 |
Q02 2020 | 0.58 | 0.71 | 22.41 |
Q01 2020 | 0.81 | 0.81 | 0.00 |
Q04 2019 | 0.86 | 0.89 | 3.49 |
Q03 2019 | 0.72 | 0.76 | 5.56 |
Q02 2019 | 0.72 | 0.71 | -1.39 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
4/2021 QR | 0.81 | -3.57 | Negative |
7/2021 QR | 0.90 | 2.27 | Positive |
10/2021 FY | 3.86 | 5.75 | Positive |
10/2022 FY | 4.33 | 5.10 | Positive |
Next Report Date | - |
Estimated EPS Next Report | 0.89 |
Estimates Count | 8 |
EPS Growth Next 5 Years % | 9.00 |
Volume Overview | |
---|---|
Volume | 2.53M |
Shares Outstanding | 305.39M |
Trades Count | 34.99K |
Dollar Volume | 246.20M |
Avg. Volume | 1.72M |
Avg. Weekly Volume | 1.55M |
Avg. Monthly Volume | 1.74M |
Avg. Quarterly Volume | 1.69M |
Agilent Technologies Inc. (NYSE: A) stock closed at 114.99 per share at the end of the most recent trading day (a -3.61% change compared to the prior day closing price) with a volume of 2.73M shares and market capitalization of 35.12B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 16400 people. Agilent Technologies Inc. CEO is Michael R. McMullen.
The one-year performance of Agilent Technologies Inc. stock is 36.37%, while year-to-date (YTD) performance is -2.95%. A stock has a five-year performance of 192.3%. Its 52-week range is between 61.13 and 136.98, which gives A stock a 52-week price range ratio of 71.01%
Agilent Technologies Inc. currently has a PE ratio of 47.00, a price-to-book (PB) ratio of 7.76, a price-to-sale (PS) ratio of 6.87, a price to cashflow ratio of 31.20, a PEG ratio of 2.32, a ROA of 8.07%, a ROC of 10.83% and a ROE of 16.03%. The company’s profit margin is 14.50%, its EBITDA margin is 22.60%, and its revenue ttm is $5.53 Billion , which makes it $18.11 revenue per share.
Of the last four earnings reports from Agilent Technologies Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.89 for the next earnings report. Agilent Technologies Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Agilent Technologies Inc. is Moderate Buy (1.92), with a target price of $136.25, which is +18.49% compared to the current price. The earnings rating for Agilent Technologies Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Agilent Technologies Inc. has a dividend yield of 0.62% with a dividend per share of $0.78 and a payout ratio of 31.00%.
Agilent Technologies Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 11.73, ATR14 : 3.95, CCI20 : -135.71, Chaikin Money Flow : -0.30, MACD : -0.28, Money Flow Index : 52.04, ROC : -6.76, RSI : 39.89, STOCH (14,3) : 0.28, STOCH RSI : 0.00, UO : 38.39, Williams %R : -99.72), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Agilent Technologies Inc. in the last 12-months were: Dominique Grau (Option Excercise at a value of $1 112 548), Dominique Grau (Sold 41 789 shares of value $4 754 602 ), Heidi Kunz (Sold 20 784 shares of value $1 891 323 ), Jacob Thaysen (Sold 16 000 shares of value $1 384 480 ), Michael R. McMullen (Option Excercise at a value of $2 844 650), Michael R. McMullen (Sold 204 024 shares of value $21 162 790 ), Michael Tang (Sold 11 499 shares of value $1 269 216 ), Rodney Gonsalves (Option Excercise at a value of $379 073), Rodney Gonsalves (Sold 15 757 shares of value $1 618 101 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Moderate Buy | Moderate Buy | Moderate Buy |
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2020 sales), cross lab (36% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (33%) and China (20%) representing the largest country concentrations.
CEO: Michael R. McMullen
Teplephone: +1 800 227-9770
Address: 5301 Stevens Creek Boulevard, Santa Clara 95051, CA, US
Number of employees: 16 400
Copyright (c) 2021. All rights reserved. Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE BZX (BATS) real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2021. All market data is provided by Barchart Solutions. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.